Cc1ccc(-n2nc(C)c3c(C)cc(=O)n(CC(=O)Nc4ccc(Br)cc4F)c32)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?